nDatalyze Corp. Unveils Promising Clinical Study Outcomes

nDatalyze Corp (TSE:NDAT) has released an update.

nDatalyze Corp. reports that their innovative clinical study showcases promising results, indicating that their expert-guided approach to predicting depression probabilities outperforms standard machine learning methods. This breakthrough suggests potential for developing two distinct, cost-effective product pathways that leverage machine learning with minimal recalibration.

For further insights into TSE:NDAT stock, check out TipRanks’ Stock Analysis page.